Absci
More News
-
AstraZeneca, AI biologics firm Absci tie up on cancer drug
AstraZeneca signs deal worth $247 million with AI biologists Absci to design new antibody to fight cancer
AstraZeneca signs deal worth $247 million with AI biologists Absci to design new antibody to fight cancer
This material may not be published, broadcast, rewritten, redistributed or derived from. Unless otherwise stated, all content is copyrighted © 2026 The Express Tribune.